Statements (54)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:virus
|
gptkbp:cause |
cytomegalovirus infection
|
gptkbp:complications |
gptkb:pneumonia
gptkb:multiple_sclerosis hepatitis hearing loss developmental delays vision loss gastrointestinal disease |
gptkbp:diagnosis |
blood test
serology PCR testing viral culture |
gptkbp:discovery_year |
gptkb:1956
|
gptkbp:diseases |
congenital CMV infection
mononucleosis-like syndrome |
gptkbp:epidemiology |
common in HIV patients
common in immunocompromised patients common in newborns common in organ transplant recipients |
gptkbp:family |
gptkb:Herpesviridae
|
gptkbp:genus |
gptkb:Cytomegalovirus
|
gptkbp:has_been_restored |
immunosuppression
|
https://www.w3.org/2000/01/rdf-schema#label |
cytomegalovirus
|
gptkbp:is_compared_to |
60-90% in adults
|
gptkbp:is_vulnerable_to |
none available
|
gptkbp:originated_in |
fibroblasts
endothelial cells epithelial cells |
gptkbp:performance |
yes
|
gptkbp:prevalence |
common worldwide
|
gptkbp:prevention |
hygiene practices
|
gptkbp:research_focus |
vaccine development
treatment optimization improving diagnostics understanding latency mechanisms |
gptkbp:risk_factor |
pregnant women
newborns immunocompromised individuals |
gptkbp:seed_dispersal |
double-stranded DNA
|
gptkbp:size |
200-300 nm
|
gptkbp:symptoms |
fatigue
fever muscle aches swollen glands |
gptkbp:transmission |
bodily fluids
|
gptkbp:treatment |
gptkb:immunotherapy
gptkb:cidofovir prevent complications foscarnet ganciclovir reduce viral load |
gptkbp:bfsParent |
gptkb:multiple_sclerosis
|
gptkbp:bfsLayer |
4
|